women are at low risk for developing BRCA-mutation-associated breast or ovarian cancer. Furthermore, they found fair evidence of ethical, legal, and social harms associated with testing and cited ...

A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

Jewish people in England are being invited to take part in a gene testing programme to identify carriers of BRCA mutations that elevate their risk of breast cancer. The NHS Jewish BRCA Testing ...